KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cardinal Health (CAH) Operating Expenses (2016 - 2025)

Cardinal Health (CAH) has disclosed Operating Expenses for 17 consecutive years, with $1.5 billion as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 15.97% to $1.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.9 billion through Dec 2025, up 10.9% year-over-year, with the annual reading at $5.5 billion for FY2025, 5.7% up from the prior year.
  • Operating Expenses hit $1.5 billion in Q4 2025 for Cardinal Health, up from $1.5 billion in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $1.5 billion in Q4 2025 to a low of $1.1 billion in Q3 2021.
  • Historically, Operating Expenses has averaged $1.3 billion across 5 years, with a median of $1.2 billion in 2022.
  • Biggest five-year swings in Operating Expenses: dropped 3.58% in 2021 and later increased 15.97% in 2025.
  • Year by year, Operating Expenses stood at $1.2 billion in 2021, then increased by 3.28% to $1.2 billion in 2022, then increased by 8.36% to $1.3 billion in 2023, then rose by 1.47% to $1.3 billion in 2024, then rose by 15.97% to $1.5 billion in 2025.
  • Business Quant data shows Operating Expenses for CAH at $1.5 billion in Q4 2025, $1.5 billion in Q3 2025, and $1.5 billion in Q2 2025.